Clinical trial
Vaccine Therapy in Treating Patients With Stage IV Melanoma
NCT00126685 · Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum Erlangen, Other · Unknown status
Key facts
| NCT number | NCT00126685 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Stage IV Melanoma |
| Official title | Vaccination of Stage IV Cutaneous Melanoma Patients With Mature, Autologous Monocyte-Derived Dendritic Cells Transfected With Unselected Autologous Amplified Tumor-RNA |
| Lead sponsor | Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum Erlangen, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological |
| Interventions | autologous tumor cell vaccine, therapeutic autologous dendritic cells |
| Enrollment | 30 |
| Start date | Apr 1, 2005 |
| First posted | Aug 4, 2005 |
| Last update posted | Sep 17, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: